Next-Gen VNS Platform
Epilepsy & Depression
DevelopmentActive
Key Facts
About LivaNova
LivaNova PLC is a publicly traded medical device company formed from the strategic merger of Sorin Group and Cyberonics, unifying cardiovascular and neuromodulation expertise. Its mission is to change the trajectory of lives through two core platforms: VNS Therapy™ for neurological disorders and the Essenz™ Perfusion System for cardiopulmonary surgery. The company has established strong commercial footprints in both therapeutic areas and is advancing its pipeline to expand indications and integrate digital health capabilities. LivaNova's strategy hinges on leveraging deep clinical evidence, driving operational excellence, and pursuing disciplined innovation to address significant unmet medical needs.
View full company profile